Examples of 'infusion-related reactions' in a sentence
Meaning of "infusion-related reactions"
infusion-related reactions: These are adverse effects or responses that can occur in response to an infusion or introduction of a substance into the body, often related to medical treatments or therapies
How to use "infusion-related reactions" in a sentence
Basic
Advanced
infusion-related reactions
See also infusion-related reactions below.
The most common adverse reactions were infusion-related reactions.
Infusion-related reactions were reported for this patient.
Patients experiencing infusion-related reactions.
Infusion-related reactions and hypersensitivity.
No patients were withdrawn from treatment due to infusion-related reactions.
Nearly all infusion-related reactions were mild to moderate.
Intravenous ofatumumab has been associated with infusion-related reactions.
Infusion-related reactions were reported in clinical studies with ramucirumab.
General disorders and administration site conditions infusion-related reactions.
Two percent of the infusion-related reactions led to discontinuation of treatment.
Use of concomitant immunosuppressant agents appeared to reduce the frequency of infusion-related reactions.
Infusion-related reactions have been reported with belatacept administration in clinical studies.
With bolus injection, an increased incidence of infusion-related reactions may be expected.
The frequency of infusion-related reactions decreased over time with continued treatment.
See also
Interrupt or slow the rate of infusion for mild or moderate infusion-related reactions.
Serious but uncommon infusion-related reactions include anaphylaxis severe allergic reaction.
Olaratumab is associated with serious risks, including infusion-related reactions and embryofetal harm.
Severe infusion-related reactions may commonly occur, in rare cases with fatal outcome.
Rats in the high dose group experienced infusion-related reactions that were exacerbated by anaesthesia.
Infusion-related reactions drug hypersensitivity, anaphylactic reaction, hypersensitivity and cytokine release syndrome.
The most commonly reported events considered as ADRs were infusion-related reactions and infections.
The majority of infusion-related reactions developed after the first or second administration of necitumumab.
Patients may also be given other medicines to prevent infusion-related reactions and other side effects.
Infusion-related reactions occur predominantly during the first infusion and tend to decrease with subsequent infusions.
Denotes adverse reactions that are reported largely in association with Infusion-related reactions.
Infusion-related reactions may occur during treatment with Lartruvo.
On the first day of the infusion, Provenge may cause infusion-related reactions such as.
Infusion-related reactions may occur during treatment with Portrazza.
The ADR reports on Remicade classified as serious describe infections and infusion-related reactions.
Infusion-related reactions were reported in 4 % of patients receiving vedolizumab.
Management of infusion-related reactions.
Infusion-related reactions IRRs.
Twenty-three percent of patients developed infusion-related reactions.
Headache infusion-related reactions.
Patients should be monitored during infusion for signs of infusion-related reactions see section 4.4.
Infusion-related reactions and infections, which were mostly mild to.
Post-infusion medications should be administered to reduce the risk of delayed infusion-related reactions as follows,.
Severe infusion-related reactions have been reported in patients receiving pembrolizumab see section 4.8.
In treatment-naïve patients, the majority of infusion-related reactions occurred during the first 6 months of treatment.
Infusion-related reactions were defined as all events occurring during or within 24 hours of an infusion.
Two out of 86 patients ( with most patients receiving 5 treatments ) experienced multisystem infusion-related reactions with retreatment.
Acute infusion-related reactions ( IRRs ) have been observed in patients treated with mogamulizumab.
The most serious adverse reactions were immune-related adverse reactions and severe infusion-related reactions see section 4.4.
Severe infusion-related reactions have been reported in patients treated with cetuximab see section 4.8.
Table 1 - Management recommendations for infusion-related reactions IRRs.
Infusion-related reactions ( IRRs ), including anaphylactic reactions, were reported in clinical trials with olaratumab.
Atezolizumab should be permanently discontinued in patients with Grade 3 or 4 infusion-related reactions.
Infusion-related reactions can happen during the infusion or up to 24 hours after the infusion.
KEYTRUDA can also cause severe or life-threatening infusion-related reactions.
You'll also be interested in:
Examples of using Infusion-related
Show more
See also infusion-related reactions below
See above recommendations in case of infusion-related reaction
Severe infusion-related side effects include
Examples of using Reactions
Show more
Allergic reactions can occur in different ways
It is quite clear that your reactions are automatic
Chemical reactions involve change on two levels
